Drug therapy of Alzheimer's disease. General concepts on nootropic drugs
Otomo, E.
Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1569-1574
1988
ISSN/ISBN: 0047-1852 PMID: 3221464 Document Number: 325621
Document emailed within 1 workday
Related Documents
Lacomblez, L. 1998: Drug therapy strategies in Alzheimer's disease La Revue du Praticien 48(17): 1913-1917Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96
Musiek, E.S.; Schindler, S.E. 2013: Alzheimer disease: current concepts and future directions Missouri Medicine 110(5): 395-400
DE Felice, F.G.; Houzel, J-Christophe.; Garcia-Abreu, Jé.; Louzada, P.Roberto.F.; Afonso, R.C.; Meirelles, M.Nazareth.L.; Lent, R.; Neto, V.Moura.; Ferreira, Sérgio.T. 2001: Inhibition of Alzheimer's disease β-amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapy FASEB Journal 15(7): 1297-1299
Palmer, J.D.; Bressler, R. 1974: Drug--drug interactions. A general discussion about how and where drugs may interact in the body Arizona Medicine 31(2): 89-93
Orhan, I.Erdogan. 2012: Current concepts on selected plant secondary metabolites with promising inhibitory effects against enzymes linked to Alzheimer's disease Current Medicinal Chemistry 19(14): 2252-2261
MacKenzie, I.R. 1996: Antiinflammatory drugs in the treatment of Alzheimer's disease Journal of Rheumatology 23(5): 806-808
Deleuze, J. 2011: The minimum efficiency of drugs against Alzheimer's disease La Revue du Praticien 61(9): 1187
1979: Adverse Drug Reactions Advisory Committee. Peyronie's disease. A complication in therapy with beta-adrenoreceptor blocking drugs? Medical Journal of Australia 2(8): 432
Skausig, O.Bjørn.; Laugesem, L.P.; Jensen, T. 2003: Drug therapy of Alzheimer dementia Ugeskrift for Laeger 165(29): 2899; Author Reply 2899-900
Giurgea, C.E.; Greindl, M.G.; Preat, S. 1983: Nootropic drugs and aging Acta Psychiatrica Belgica 83(4): 349-358
Peng, Y.; Li, P-ping.; Li, L.; Zhang, Y.; Hou, W-zhen.; Cui, D-dan.; Li, J.; Wang, L.; Wang, Q-li.; Wang, X-liang. 2016: Progress of clinical trials in Alzheimer's disease drugs Yao Xue Xue Bao 51(8): 1185-1195
Warner, J.; Butler, R. 2001: Drugs for Alzheimer's disease. more effective agents are needed Bmj 323(7321): 1127-1128
Clader, J.W. 1999: Recent advances in cholinergic drugs for Alzheimer's disease Current Opinion in Drug Discovery and Development 2(4): 311-320
Graber, H. 1990: Rational antibiotic therapy: new drugs, changing concepts Therapia Hungarica 38(3): 99-105
Mulligan, R.; Juillerat, A.C. 1997: Non-drug alternatives in Alzheimer disease Praxis 86(35): 1355-1358
Derouesné, C.; Baudouin-Madec, V.; Kerromes, I. 1998: Non-drug management of Alzheimer's disease La Revue du Praticien 48(17): 1918-1922
2003: Antibodies, antihypertensive drugs, antioxidants. Can they prevent Alzheimer disease? MMWFortschrittederMedizin 145(33-34): 60
De Jong, D.; Jansen, R.W.M.M.; Verbeek, M.M.; Kremer, H.P.H. 2002: The possible suppression of Alzheimer's disease by nonsteroidal anti-inflammatory drugs Nederlands Tijdschrift Voor Geneeskunde 146(44): 2074-2078
Nordberg, A.; Eriksdotter-Jönhagen, M.; Garlind, A.; Grut, M.; Freund-Levi, Y.; Cornelius, C.; Ekström, A.; Fastbom, J.; Sedvall, M.; Viitanen, M. 2006: Administration of symptom-relieving drugs in Alzheimer disease is beneficial Lakartidningen 103(6): 369-371